These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33684315)

  • 21. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
    Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
    J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
    Mac S; Fitzpatrick T; Johnstone J; Sander B
    Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis on the prevalence of vancomycin-resistant enterococci (VRE) among Nigerians.
    Orababa OQ; Soriwei JD; Akinsuyi SO; Essiet UU; Solesi OM
    Porto Biomed J; 2021; 6(1):e125. PubMed ID: 33884321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.
    Cheah ALY; Cheng AC; Spelman D; Nation RL; Kong DCM; McBryde ES
    BMC Infect Dis; 2018 Oct; 18(1):511. PubMed ID: 30309313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: a systematic review and meta-analysis.
    Smout E; Palanisamy N; Valappil SP
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):79. PubMed ID: 37605268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.
    Chiang HY; Perencevich EN; Nair R; Nelson RE; Samore M; Khader K; Chorazy ML; Herwaldt LA; Blevins A; Ward MA; Schweizer ML
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):203-215. PubMed ID: 27825401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia.
    Somily AM; Al-Mohizea MM; Absar MM; Fatani AJ; Ridha AM; Al-Ahdal MN; Senok AC; Al-Qahtani AA
    Microb Pathog; 2016 Aug; 97():79-83. PubMed ID: 27247096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
    Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
    Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
    Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.
    Monteserin N; Larson E
    J Hosp Infect; 2016 Nov; 94(3):236-241. PubMed ID: 27645212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of Prevalence, Characteristics, Risk Factors, Resistance, and Virulence of Vancomycin-Resistant Enterococci in Saudi Arabia.
    Abdallah M; Al-Saafin M
    Microb Drug Resist; 2019 Apr; 25(3):350-358. PubMed ID: 30325688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-resistant enterococci isolates colonizing and infecting haematology patients: clonality, and virulence and resistance profile.
    Marchi AP; Perdigão Neto LV; Martins RCR; Rizek CF; Camargo CH; Moreno LZ; Moreno AM; Batista MV; Basqueira MS; Rossi F; Amigo U; Guimaraes T; Levin AS; Costa SF
    J Hosp Infect; 2018 Jul; 99(3):346-355. PubMed ID: 29066140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin-resistant enterococci and coagulase-negative staphylococci prevalence among patients attending at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
    Ashagrie D; Genet C; Abera B
    PLoS One; 2021; 16(4):e0249823. PubMed ID: 33831089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak.
    Fossi Djembi L; Hodille E; Chomat-Jaboulay S; Coudrais S; De Santis N; Gardes S; Mauranne CC; Mourey N; Fredenucci I; Girard R
    J Infect Public Health; 2017; 10(2):185-190. PubMed ID: 27140696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and risk factors of methicillin-resistant
    Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
    Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of nosocomial bloodstream infections and nosocomial vancomycin-resistant Enterococcus faecium on an intensive care unit after introduction of antiseptic octenidine-based bathing.
    Messler S; Klare I; Wappler F; Werner G; Ligges U; Sakka SG; Mattner F
    J Hosp Infect; 2019 Mar; 101(3):264-271. PubMed ID: 30408504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid monitoring of vancomycin-resistant Enterococcus faecium in hospital departments by repetitive element palindromic polymerase chain reaction.
    Froeschen F; Gajdiss M; Uebele J; Meilaender A; Hoerauf A; Exner M; Molitor E; Bierbaum G; Engelhart S; Bekeredjian-Ding I
    J Hosp Infect; 2018 Jun; 99(2):208-217. PubMed ID: 29203445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    Patel R; Gallagher JC
    Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.